Pivotal Research Reaffirms Their Hold Rating on Balchem Corp (BCPC)


Pivotal Research analyst Timothy Ramey maintained a Hold rating on Balchem Corp (NASDAQ: BCPC) today and set a price target of $95. The company’s shares opened today at $94.93.

Ramey wrote:

“We are raising our adjusted EPS estimates to $3.05 for 2018 and $3.35 for 2019 ($2.95 and $3.20 previously). We continue to view the company as very attractive, but the shares remain fully-priced. We are boosting our price target to $95 from $85 based on 28.4x 2019 EPS; The shares trade today at 19.3x EV/EBITDA. FCF yield is only 3%. BCPC has done a superb job, we can only hope for a better entry point.”

According to TipRanks.com, Ramey is a 5-star analyst with an average return of 12.6% and a 68.4% success rate. Ramey covers the Consumer Goods sector, focusing on stocks such as Constellation Brands Inc, Post Holdings Inc, and Brown-Forman B.

Currently, the analyst consensus on Balchem Corp is a Hold with an average price target of $95.

See today’s analyst top recommended stocks >>

Based on Balchem Corp’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $19.35 million. In comparison, last year the company had a net profit of $16.54 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Balchem Corp. engages in the development, manufacture, and marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products, and Industrial Products.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts